Table of Contents
DUBLIN — Allergan announced the launch of Spotlyte – an innovative digital hub of curated content that helps consumers discover how medical aesthetic treatments may fit into their routines. Through well-researched content, product reviews and insider profiles, together with the latest beauty news and trends, the site functions as a holistic and informative lens into these worlds. Beyond the editorial, Spotlyte will provide access to a team of trained specialists ready to offer real-time support and chat directly with anyone considering medical aesthetic treatments, as well as help connect readers to local licensed providers.
Led by Alexandra Wilkis Wilson, co-founder of Gilt Groupe and Glamsquad, and appointed senior vice president of Consumer Strategy and Innovation at Allergan, Spotlyte is the first venture from the new Allergan-owned digital ventures unit, Project Moonwalker. Dedicated to creating consumer facing businesses that unlock opportunities in the medical aesthetics category, Project Moonwalker will serve as a launchpad for new innovations that capitalize on a growing market.
“We have a unique position as industry leaders to identify emerging trends in real time and change the way that consumers engage with medical aesthetics,” said Alexandra Wilkis Wilson. “I have spent most of my career focused on the consumer while creating powerful brands at the intersection of technology and lifestyle. The core goal of Project Moonwalker is to enable information flow and access. Spotlyte is the first step in changing how consumers can become better educated on medical aesthetics.”
Consumers seek more information and don’t always know where to go or who to trust. There are over 65 million Americans considering a variety of medical aesthetic treatments (from facial injectables to body contouring and breast implants) with approximately 30% citing lack of information as the top barrier to conversion. Allergan sees a huge opportunity to propel the aesthetics market forward by going direct to consumers.
“As the market leader in medical aesthetics, we have the opportunity and the responsibility to properly educate consumers and mainstream the conversation around aesthetic treatments. We want to create an open dialogue by incorporating medical aesthetics into the overall aesthetics conversation,” said Brent Saunders, chief executive officer of Allergan. “We believe the medical aesthetics market will double in 5 to 7 years.”
The site is brand agnostic, with the goal of educating consumers and providing well researched and accurate information on medical aesthetics. For those who are curious or want to learn more, the on-site chat feature connects consumers to a specialist who will offer information and help make connections to local licensed providers.
